View Author
patient treatment lymphoma scintigraphy disease ss-r scintigraphy study chemotherapy hodgkin group result fatigue lesion therapy trial table lymph stage cancer somatostatin radiotherapy infection cycle receptor posaconazole imaging tumor prophylaxi netherland analysis lymph nodes somatostatin receptor scintigraphy sensitivity lamberts swj aplastic anaemia number strain rotterdam aplastic marrow prognostic survival value mopp-abv university month blood gallium oncol transplantation liposomal amphotericin b subtotal nodal radiotherapy region involvement amphotericin mortality evaluation level /medium fatigue vs krenning ep score period crbsi ct scanning somatostatin receptors reubi jc t-cell scanning incidence anaemia ethanol krenning episode lambert outcome response chapter catheter reubi comparison
10 Most Recent Publications
|
Intensified alemtuzumab-CHOP therapy for peripheral T-cell lymphoma
(Article)
Kluin-Nelemans, H.C. Marwijk Kooy, M. van Lugtenburg, P.J. Putten, W.L.J. van Luten, M. Oudejans, J. Imhoff, G. van |
2011-07-04
|
|
Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: A randomized, placebo-controlled trial
(Article)
Slobbe, L. Doorduijn, J.K. Lugtenburg, P.J. Barzouhi, A.E. Boersma, H. Leeuwen, W.B. van Rijnders, B.J.A. |
2010-09-17
|
|
Economic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the Netherlands
(Article)
Jansen, J.P. O'Sullivan, A.K. Lugtenburg, P.J. Span, L.F.R. Janssen, J.J.W.M. Stam, W.B. |
2010-09-01
|
|
Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial
(Article)
Heutte, N. Flechtner, H.H. Thomas, J. Lugtenburg, P.J. Viterbo, L. Carde, P. Hagenbeek, A. Maazen, R.W. van der Smit, W.G. Brice, P. Marwijk Kooy, M. van Baars, J.W. Mounier, N. Poortmans, P. Tirelli, U. Leeksma, O.C. Tomšič, R. Feugier, P. Salles, G. Gabarre, J. Kersten, M.J. Neste, E. van den Creemers, G.J.M. Mellink, W.A. Gaillard, I. Meijnders, P. Tertian, G. Reman, O. Muller, H.P. Troncy, J. Blanc, M. Schroyens, W. Voogt, P.J. Wijermans, P. Meerwaldt, J.H. Rieux, C. Fermé, C. Henry-Amar, M. Eghbali, H. Veer, M.B. van 't Noordijk, E.M. Kluin-Nelemans, J.C. Lampka, E. |
2009-12-01
|
|
Three-day treatment with imipenem for unexplained fever during prolonged neutropaenia in haematology patients receiving fluoroquinolone and fluconazole prophylaxis: A prospective observational safety study
(Article)
Slobbe, L. Waal, L.v.d. Jongman, L.R. Lugtenburg, P.J. Rijnders, B.J.A. |
2009-11-01
|
|
Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: An observational study
(Article)
Slobbe, L. Polinder, S. Doorduijn, J.K. Lugtenburg, P.J. El Barzouhi, A. Steyerberg, E.W. Rijnders, B.J.A. |
2008-12-15
|
|
Treatment of diffuse large B-cell lymphoma in the elderly: strategies integrating oncogeriatric themes.
(Article)
Lugtenburg, P.J. Sonneveld, P. |
2008-12-01
|
|
Economic evaluation of posaconazole vs. standard azole prophylaxis in high risk neutropenic patients in the Netherlands
(Article)
Stam, W.B. O'Sullivan, A.K. Rijnders, B.J.A. Lugtenburg, P.J. Span, L.F.R. Janssen, J.J.W.M. Jansen, J.P. |
2008-12-01
|
|
Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: A randomized, placebo-controlled trial
(Article)
Rijnders, B.J.A. Cornelissen, J.J. Marie, S. de Slobbe, L. Becker, M.J. Doorduijn, J.K. Hop, W.C.J. Ruijgrok, E.J. Löwenberg, B. Vulto, A.G. Lugtenburg, P.J. |
2008-05-01
|
|
Anti-müllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies
(Article)
Lie Fong, S. Lugtenburg, P.J. Schipper, I. Themmen, A.P.N. Jong, F.H. de Sonneveld, P. Laven, J.S.E. |
2008-03-01
|
